[
  {
    "ts": "2025-04-22T14:01:58+00:00",
    "headline": "Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break",
    "summary": "Upslope Capital Management, an investment management firm, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The First quarter was challenging for the fund. However, the world has transformed in the two weeks since March 31, due to a drastic realignment of international trade rules. As a result, markets […]",
    "url": "https://finance.yahoo.com/news/upslope-capital-management-sold-charles-140158787.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ebc66d38-02f7-3a35-a75d-d431dc9c4adf",
      "content": {
        "id": "ebc66d38-02f7-3a35-a75d-d431dc9c4adf",
        "contentType": "STORY",
        "title": "Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break",
        "description": "",
        "summary": "Upslope Capital Management, an investment management firm, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The First quarter was challenging for the fund. However, the world has transformed in the two weeks since March 31, due to a drastic realignment of international trade rules. As a result, markets […]",
        "pubDate": "2025-04-22T14:01:58Z",
        "displayTime": "2025-04-22T14:01:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/0e857ae9b0144d1996b14fb908ea3840",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/brh3fJuygdiS8j7qgVO3lQ--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/0e857ae9b0144d1996b14fb908ea3840.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FkjVFWm.A9_NXt5p9KTolg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/0e857ae9b0144d1996b14fb908ea3840.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/upslope-capital-management-sold-charles-140158787.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/upslope-capital-management-sold-charles-140158787.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-04-22T12:00:00+00:00",
    "headline": "Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development",
    "summary": "WILMINGTON, Mass., April 22, 2025--Ahead of AACR 2025, Charles River announces updates to its comprehensive portfolio to support the discovery and development of novel oncology drugs.",
    "url": "https://finance.yahoo.com/news/charles-river-leverages-advanced-technology-120000774.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "7126cf85-aefe-3f36-b962-243d138cc641",
      "content": {
        "id": "7126cf85-aefe-3f36-b962-243d138cc641",
        "contentType": "STORY",
        "title": "Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development",
        "description": "",
        "summary": "WILMINGTON, Mass., April 22, 2025--Ahead of AACR 2025, Charles River announces updates to its comprehensive portfolio to support the discovery and development of novel oncology drugs.",
        "pubDate": "2025-04-22T12:00:00Z",
        "displayTime": "2025-04-22T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/38eb30c08319b52de80f69bc4641ec81",
          "originalWidth": 1245,
          "originalHeight": 326,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sPZ7x7z6SQh2CV1mmndGow--~B/aD0zMjY7dz0xMjQ1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/38eb30c08319b52de80f69bc4641ec81.cf.webp",
              "width": 1245,
              "height": 326,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YjXrSUrOCRZOLyKz3MNQbg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/38eb30c08319b52de80f69bc4641ec81.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-leverages-advanced-technology-120000774.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-leverages-advanced-technology-120000774.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]